Providence Cancer Institute of Oregon

  • Studies to be presented by Providence researchers at AACR annual meeting

    Studies to be presented by Providence researchers at AACR annual meeting

    The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

    Read Article
  • Seeking better treatments for people with ER+/HER- breast cancer

    Seeking better treatments for people with ER+/HER- breast cancer

    Two studies for people with ER+/HER2- breast cancer are enrolling patients at Providence Cancer Institute.

    Read Article
  • From life-saving surgery to back on the slopes: A photographer’s story

    From life-saving surgery to back on the slopes: A photographer’s story

    Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.

    Read Article
  • Robotic versus open surgery for early cervical cancer

    Robotic versus open surgery for early cervical cancer

    This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.

    Read Article
  • A year to remember: Advancements, recognition and transitions

    A year to remember: Advancements, recognition and transitions

    Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

    Read Article
  • CAR T cell-therapy, hope and healing: Dean’s story

    CAR T cell-therapy, hope and healing: Dean’s story

    Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.

    Read Article
  • Two clinical trials for solid tumor cancers take different approaches to stop growth

    Two clinical trials for solid tumor cancers take different approaches to stop growth

    Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.

    Read Article
  • Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains

    Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains

    R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

    Read Article
  • Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

    Read Article
  • New studies test immunotherapy to boost breast cancer treatment and prevent return

    New studies test immunotherapy to boost breast cancer treatment and prevent return

    Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

    Read Article
  • Attend a free virtual symposium on melanoma, Oct. 25

    Attend a free virtual symposium on melanoma, Oct. 25

    Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

    Read Article
  • Prostate cancer study includes a tumor test to personalize treatment

    Prostate cancer study includes a tumor test to personalize treatment

    A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

    Read Article
  • Dr. Walter Urba announces retirement from Providence

    Dr. Walter Urba announces retirement from Providence

    Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

    Read Article
  • Dr. Bernard Fox honored for his lifetime contributions to cancer research

    Dr. Bernard Fox honored for his lifetime contributions to cancer research

    Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.

    Read Article
  • Can these new studies offer hope for people with lung and head and neck cancers?

    Can these new studies offer hope for people with lung and head and neck cancers?

    A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

    Read Article
  • Cancer survivor speaks with doctor he credits for saving his life

    Cancer survivor speaks with doctor he credits for saving his life

    Cancer survivor Mark Williams chats with Dr. Brendan Curti about

    Read Article
  • 2024 Hood to Coast Relay: Providence team captains tell us why they run

    2024 Hood to Coast Relay: Providence team captains tell us why they run

    What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

    Read Article
  • Promising advances in treating TNBC: Two studies offer hope

    Promising advances in treating TNBC: Two studies offer hope

    Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.

    Read Article
  • Targeting cancer cells: Two studies take different approaches

    Targeting cancer cells: Two studies take different approaches

    A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

    Read Article
  • The evolution of cancer immunotherapy: Dr. Urba shares his insights

    The evolution of cancer immunotherapy: Dr. Urba shares his insights

    Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

    Read Article
  • loading
    Loading More...